Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 600x60px
Document › Details

Biognosys AG. (10/18/13). "Press Release: US Patent Awarded to Biognosys".

Region Region United States (USA)
Organisations Organisation Biognosys AG
  Organisation 2 ETH Zürich (ETHZ)
Products Product SRM (Selected Reaction Monitoring)
  Product 2 multiple reaction monitoring (MRM) technology

We are happy to announce that a core patent from ETH Zurich which is exclusively licensed to Biognosys was granted in the US (US8501421 B2) and the corresponding application is pending in Europe. The patent describes a method (Picotti et al. 2009) for efficient development of SRM/MRM assays using, for example, synthetic peptide libraries.

With increasing demand for quantitative multiplexed proteomics the development and validation of assays becomes a bottleneck. This patent enables Biognosys to protect a key process in high-content targeted proteomics experiments.

Record changed: 2016-01-10


Picture EBD Group Biotech Showcase 2019 San Francisco BTS January 600x60px

More documents for Biognosys AG

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

» top